Disability of Development of Tolerance to Morphine and U-50,488H, A Selective κ-Opioid Receptor Agonist, in Neuropathic Pain Model Mice

Journal of Pharmacological Sciences

Volumn 94, Issue 3, 2004, Pages 305-312

  Sounvoravong, Sourisak ^a   Takahashi, Masakatsu ^a   Nakashima, Mihoko N ^a   Nakashima, Kennichiro ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Allodynia; Analgesia; Neuropathic pain; Opioid; Tolerance

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; KAPPA OPIATE RECEPTOR AGONIST; MORPHINE DERIVATIVE;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERANCE; HYPERALGESIA; MALE; MOUSE; NERVE LIGATION; NEUROPATHIC PAIN; NONHUMAN; SCIATIC NERVE;

EID: 1842682299     PISSN: 13478613     EISSN: None     Source Type: Journal    
DOI: 10.1254/jphs.94.305     Document Type: Article

References (30)

1. Seltzer Z, Dubner R, Shir Y. A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain. 1990;43:205-218.
2. Ochoa JL, Yarnitsky D. Mechanical hyperalgesias in neuropathic pain patients; dynamic and static subtypes. Ann Neurol. 1993;33:465-472.
3. Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 1988;33:87-107.
4. Mao J, Price DD, Mayer DJ. Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain. Pain. 1995;61:353-364.
5. Suzuki R, Chapman V, Dickenson AH. The effectiveness of spinal and systemic morphine on rat dorsal horn neuronal responses in the spinal nerve ligation model of neuropathic pain. Pain. 1999;80:215-228.
6. Arner S, Meyerson BA. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain. 1988;33:11-23.
7. Rowbotham MC, Reisner-Keller LA, Fields HL. Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology. 1991;41:1024-1028.
8. Field MJ, Bramwell S, Hughes J, Singh L. Detection of static and dynamic components of mechanical allodynia in rat models of neuropathic pain: are they signalled by distinct primary sensory neurones? Pain. 1999;83:303-311.
9. Field MJ, McCleary S, Hughes J, Singh L. Gabapentin and pregabalin, but not morphine and amitriptyline, block both static and dynamic components of mechanical allodynia induced by streptozocin in the rat. Pain. 1999;80:391-398.
10. Catheline G, Guilbaud G, Kayser V. Peripheral component in the enhanced antinociceptive effect of systemic U-69,593, a κ-opioid receptor agonist in mononeuropathic rats. Eur J Pharmacol. 1998;357:171-178.
11. Cowan DT, Allan L, Griffiths P. A pilot study into the problematic use of opioid analgesics in chronic non-cancer pain patients. Int J Nursing Studies. 2002;39:59-69.
12. Rowbotham MC, Reisner-Keller LA, Fields HL. Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology. 1991;41:1024-1028.
13. Portenoy RK, Foley KM, Inturrisi CE. The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions. Pain. 1990;43:273-286.
14. Abbott FV, Franklin KB, Ludwick RJ, Melzack R. Apparent lack of tolerance in the formalin test suggests different mechanisms for morphine analgesia in different types of pain. Pharmacol Biochem Behav. 1981;15:637-640.
15. Vaccarino AL, Marek P, Kest B, et al. Morphine fails to produce tolerance when administered in the presence of formalin pain in rats. Brain Res. 1993;627:287-290.
16. Takagi H, Inukai T, Nakama M. A modification of Haffner's method for testing analgesics. Jpn J Pharmacol. 1966;16:287-294.
17. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods. 1994;53:55-63.
18. Woolf CJ. Evidence for a central component of post-injury pain hypersensitivity. Nature. 1983;306:686-688.
19. Simone DA, Sorkin LS, Oh U, et al. Neurogenic hyperalgesia: central neural correlates in responses of spinothalamictract neurons. J Neurophysiol. 1991;66:228-246.
20. Yaksh TL. Pharmacology and mechanisms of opioid analgesic activity. Acta Anaesthesiol Scand. 1997;41:94-111.
21. Light AR, Perl ER. Differential termination of large-diameter and small-diameter primary afferent fibres in the spinal dorsal grey matter as indicated by labelling with horseradish peroxidase. Neurosci Lett. 1977;6:59-63.
22. Minami M, Satoh M. Molecular biology of the opioid receptors: structures, functions and distributions. Neurosci Res. 1995;23:121-145.
23. Hope PJ, Fleetwood-Walker SM, Mitchell R. Distinct antinociceptive actions mediated by different opioid receptors in the region of lamina I and laminae III - V of the dorsal horn of the rat. Br J Pharmacol. 1990;101:477-483.
24. Fujimoto JM, Arts KS, Rady JJ, Tseng LF. Spinal dynorphin A (1-17): possible mediator of antianalgesic action. Neuropharmaclogy. 1990;29:609-617.
25. Song ZH, Takemori AE. Involvement of spinal kappa opioid recptors in the antagonistic effect of dynorphins on morphine antinociception. Life Sci. 1991;48:1447-1553.
26. Hao J-X, Yu W, Wiesenfield-Hallin Z, Xu D-J. Treatment of chronic allodynia in spinally injured rats: effects of intrathecal selective opioid receptor agonists. Pain. 1998;75:209-217.
27. Yamamoto T, Ohno M, Ueki S. A serective κ-opioid agonist, U-50,488H, blocks the development of tolerance to morphine analgesia in rats. Eur J Pharamcol. 1988;156:173-176.
28. Takahashi M, Senda T, Kaneto H. Role of spinal κ opioid receptors in the blockade of the development of antinociceptive tolerance to morphine. Eur J Pharmacol. 1991;200:293-297.
29. Ossipov MH, Lopez Y, Nichols ML, Bian D, Porreca F. The loss of antinociceptive efficacy of spinal morphine in rats with nerve ligation injury is prevented by reducing spinal afferent drive. Neurosci Lett. 1995;199:87-90.
30. Takahashi M, Kaneto H. Footshock and psychological-stress prevent the development of tolerance to spinal but not supraspinal morphine. Jpn J Pharmacol. 1991;56:121-126.